NCT03631004View on ClinicalTrials.gov

Pre-operative Olanzapine as Prophylactic Antiemetic in Oncologic Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

February 10, 2021

Study Completion Date

February 10, 2021

Conditions
Postoperative NauseaPostoperative Nausea and Vomiting
Interventions
DRUG

Olanzapine

olanzapine 10 mg is given before surgery

Trial Locations (1)

01403010

Cancer Institute of the State of Sao Paulo - ICESP, São Paulo

All Listed Sponsors
lead

Instituto do Cancer do Estado de São Paulo

OTHER

NCT03631004 - Pre-operative Olanzapine as Prophylactic Antiemetic in Oncologic Patients | Biotech Hunter | Biotech Hunter